The trials listed here are being conducted by pharmaceutical companies and physicians who are partnering with or have contacted the Gorlin Syndrome Alliance.

For a complete listing, please go to clinicaltrials.gov.

CURRENT CLINICAL TRIAL OPPORTUNITY

“Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas  on the Face of Adults with Gorlin Syndrome”

TRIAL:  

Clinical trial available now for topical gel to prevent basal cell skin cancers (BCCs) in people with Gorlin syndrome. 

START DATE:  

Ongoing at 30 sites worldwide

ELIGIBILITY REQUIREMENTS:

These include the following:

  • Age 18 or over
  • PTCH1 mutation as the drug works best on these people. Free genetic testing will be done at the screening visit if individual meets requirements noted below.
  • 10 or more BCCs on your face when you are screened. Specialized, high-powered photography equipment is used to identify the lesions.
  • Oral hedgehog inhibitors (Odomzo (sonidegib) or Erivedge (vismodegib)) must be stopped for 3 months prior to first visit.
  • Site visits needed: Potential participants will need to go to their chosen clinical trial site for a screening visit. If this is successful, five more in-person site visits will be needed over the course of 12 months. Virtual phone or video visits will also be necessary.
  • For more details, please go to: clinicaltrials.gov

LOCATIONS: 

30 sites worldwide, over half across the United States. See below for a detailed site list with contact information. 

EXPENSES:

All costs associated with your travel will be reimbursed fully. This includes air/bus/train fare, gas and tolls, meals, and overnight lodging as necessary. If a care partner is needed, this individuals’ expenses will be covered as well.

BENEFITS: 

  • If an individual completes the trial and the medication is FDA approved, this participant will receive the medication FREE for one year.
  • With success and FDA approval, we will have a non-surgical, non-invasive preventative therapy for BCCs in the future! YOU will have been a part of creating this opportunity for all adults with Gorlin syndrome. 
  • Free Genetic Testing (if not previously confirmed) for participants to document PTCH1 mutation.

FOR MORE INFORMATION:  

  • Information on this trial is also available in a webinar recorded in June of 2024 featuring Dr. Ervin Epstein and Julie Breneiser, Executive Director.

The following clinical trial sites listed below are currently open and actively recruiting.

NORTHEAST

Dr. JaiDe (Jeff) Yu

Location:
Massachusetts General Hospital
Clinical Unit for Research Trials and Outcomes in Skin
50 Staniford Street, Suite 240
Boston, MA 02114

Contact Information –
Trial Coordinator: Anicka Lawrence

Email:
alawrence6@mgh.harvard.edu

Phone numbers
Office: 617-726-5066
Fax: 617-724-2998

Dr. Kristin Bibee
Location:
The Johns Hopkins Hospital
The Johns Hopkins Outpatient Center
601 N. Caroline Street
8th Floor, Suite 8033
Baltimore, MD 21287

Contact Information –
Trial Coordinator:
Manager: Ruizhi Wang
Coordinator: Yage Sun

Email:
rwang@jmmi.edu
yun147@jh.edu

Phone number:
Office: 410-502-7546

Dr. Liz Billingsley

Location:
Penn State Hershey Medical Center
Penn State Health
500 University Drive
Dermatology Research UPC II, Room 2010
Hershey, PA 17033

Contact Information –

Trial Coordinator:
Samantha Gettle

Email:
sgettle2@pennstatehealth.psu.edu

Phone number:
Office: 717-531-4439
Fax: 717-531-5088

Dr. Robert Nossa

Location:
Schweiger Dermatology P.C.
60 Pompton Ave.
Verona, NJ 07044

Contact Information –

Trial Coordinator:
Malgorzata Lasoche Lopez

Email:
malgorzata.lopez@schweigerderm.com

Phone number:
Office: 929-547-0508
Fax: 973-239-8812

SOUTHEAST

Dr. Meenal Kheterpal

Location:
Duke Dermatology
Duke University School of Medicine
40 Duke Medicine Circle
Durham, NC 27710

Contact Information –

Trial coordinator:
Connor Whatley & Kristy Averette
Clinical Research Nurse Coordinator

Email: connor.whatley@duke.edu
Kristy.averette@duke.edu

Phone number:
Office: 919-681-8368

Dr. Cheryl Hull

Location:

Northwest Arkansas Clinical Trials Center, PLLC
599 S. Horsebarn Rd.
Suite 200
Rogers, AR 72758

Contact Information

Trial coordinator:
Briana Tedford, B.S.

Email: brianahullderm@yahoo.com

Phone numbers
Office: 479-876-8205, Ext. 4
Fax: 479-876-8049

Dr. James Grichnik

Location:
University of South Florida
Department of Dermatology
13330 USF Laurel Drive
Tampa, FL 33612

Contact Information –

Trial coordinator:
Lucy Lam RN, MSMS, CCRC
Email:
llam@usf.edu

Phone number:
Office: 813-974-8249

Dr. Armand Cognetta

Location:
Dermatology Associates of Tallahassee, P.A.
1707 Riggins Road
Tallahassee, FL 32308

Contact Information –

Trial coordinator:
Anna Kaji

Email: akaji@datfi.com

Phone number
Office: 805-728-7931

MIDWEST

Dr. Steve Kempers

Location:
Minnesota Clinical Study Center
119 14th Street NW
Suite 250
New Brighton, MN 48109

Contact Information –

Trial Coordinator:
Jenjira Skrei

Email:
jskrei@associatedskincare.com

Phone number:
Office:
763-571-4200

Dr. Diana Bolotin

Location:
Department of Medicine
Section of Dermatology
5841 S. Maryland Ave.
Chicago, Il 60637

Contact Information –

Trial Coordinator:
Breanna Bertacchi

Email: bbertacchi1@bsd.uchicago.edu

Phone number:
Office: 773-702-7696

Dr. Jose Garcia-Zuazaga

Location #1:
Apex Clinical Research Center
29111 Cedar Road
Mayfield Heights, OH 44124

Contact Information –

Trial coordinator:
Brooke Glivar, LPN, CCRC
Research Site Manager

Email: BGlivar@apexskin.com

Phone numbers:
Cell: 330-933-2180
Office:440-940-2739

Dr. Jose Garcia-Zuazaga

Location #2:
Apex Clinical Research Center
Apex skin Corporate Office
4124 Munson Street
Canton, OH 44718

Contact Information –

Trial coordinator:
Theresa Sedlak-Hanslik, LPN, CCRC
Research Site Manager

Email: BGlivar@apexskin.com

Phone numbers:
Cell: 330-933-2180
Office:440-940-2739

Dr. Melody Stone

Location:
MediSearch Clinical Trials
1427 Village Drive
St. Joseph, MO 64506

Contact Information –
Trial coordinator:
Healthier Jackson

Email:
Heather.Jackson@medisearchderma.com

Phone number:
Office: 816-364-1515

Dr. Mio Nakamura

Location:
University of Michigan Medicine
Department of Dermatology
1618 Taubman Center
1500E. Medical Center Drive
Ann Arbor, MI 48109

Contact Information –
Trial Coordinator:
Nicole Mahn

Email:
dermtrials@med.umich.edu

Phone number:
Office: 734-232-0562

SOUTHWEST

Dr. Timothy Rodgers

Location:
North Texas Center for Clinical Research
3880 Parkwood Blvd, Suite 102
Frisco, TX 75034

Contact Information –

Trial Coordinator:
Ashlyn Vallejo

Email: ashlyn@ntxclinicalresearch.com

Phone numbers:
Cell: 214-618-0220
Office: 940-315-5626

Dr. Lenny Henderson

Location:
SSM Health Dermatology
608 NW 9th Street, Suite 5000
Oklahoma City, OK 73102

Contact Information –

Trial coordinator:
Jessica Lackey

Email: jessica@hightowerclinical.com

Phone number:

Office: 405-579-8331

WEST

Dr. Olivia Lucero

Location:
Oregon Health & Science University
SW Bond Ave
Portland, OR 97239

Contact Information –

Trial coordinator:
Marisa Jingco
Rachel Morimoto

Email: jingco@ohsu.edu

Phone number:
Office: 503-418-9078

Dr. Michelle Aszterbaum

Location:
Dermatology Center of Newport
360 San Miguel Dr Suite 406,
Newport Beach, CA 92660

Contact Information –

Trial coordinator:
Hannah Walton

Email:
hew2018@gmail.com

Phone number:
Cell: 203-564-0030

Dr. Kavita Sarin

Location:
Stanford University School of Medicine – Department of Dermatology
455 Broadway St. Discovery Hall 1st Fl.
Redwood City, CA 94063

Contact Information:

Trial coordinator:
Dom Mitchell

Email:
domcm@stanford.edu

Phone number:
Office: 650-721-7192
Fax: 650-498-5908

Dr. Sunil Dhawan

Location:
Center for Dermatology Clinical Research, Inc.
2557 Mowry Ave., Suite 34
Fremont, CA, USA 94538

Contact Information –

Trial coordinator:
Leanne Saud, MA

Email: leannes@ctr4derm.com

Phone number:
Office: 510-797-0140, Ext. 5

Dr. April Armstrong

Location:
University of California Los Angeles
911 Broxton Ave., 3rd Floor
Los Angeles, CA 90024

Contact Information:

Trial coordinator:
Peggy Chou

Email:
PChou@mednet.ucla.edu

Phone numbers
Cell: 951-256-7538

For more information on this clinical trial, including on inclusion and exclusion criterion, please see the following resources:

Questions about Gorlin syndrome that are not related to this clinical trial should be directed to info@gorlinsyndrome.org or call 267-689-6443

Further information on this trial will be provided as soon as it becomes available.

Please consider becoming a hero to the Gorlin syndrome community by participating in this clinical trial.

Thank You